newsfilter
← Latest News
Business Wire·

GlycoMimetics Announces Its Addition to the Russell Microcap® Index

GlycoMimetics, Inc. (NASDAQ:GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced that it is set to join the